Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma

被引:7
|
作者
Wagner, Simon D.
Amen, Furrat
Trivedi, Pritesh S.
Horncastle, Donna
Elderfield, Kay
Naresh, Kikkeri N.
机构
[1] Hammersmith Hosp, Imperial Coll London, Dept Histopathol, Div Invest Sci, London W12 0NN, England
[2] Hammersmith Hosp, Imperial Coll London, Dept Haematol, Div Invest Sci, London W12 0NN, England
关键词
Bcl-6; c-Myc; lymphoma; germinal centre;
D O I
10.1080/10428190701458491
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bcl-6 is expressed in germinal centre derived B-cell non-Hodgkin lymphomas including diffuse large B-cell lymphoma (DLBCL) and is likely to play a major role in driving proliferation of a subset of DLBCLs, especially those of germinal centre B-cell subtype, but the role of c-Myc, which is important for proliferation in various lineages is not known. We used the highly standardised staining conditions of a tissue microarray to characterise co- expression of c-Myc and Bcl-6 in DLBCL. We carried out immunohistochemistry of 73 arrayed cases. The majority (62/ 73) did not express c-Myc, but 11 cases (15%) showed nuclear staining. 5/ 53 ( 9%) of Bcl-6 expressing cases co-expressed c-Myc, whereas a much higher proportion, 6/ 20 (30%), of Bcl-6 negative cases were positive for c- Myc. Overall survival of c-Myc expressing cases was the same as those that had absent expression. There was no significant correlation between c- Myc expression and DLBCL subtype (germinal centre or non- germinal centre subtypes).
引用
收藏
页码:1510 / 1513
页数:4
相关论文
共 50 条
  • [21] BCL-6 protein expression predicts improved survival in patients with diffuse large B-cell lymphoma
    Natkunam, Y
    Warnke, R
    Alizadeh, A
    Tibshirani, R
    Horning, S
    van de Rijn, M
    MODERN PATHOLOGY, 2001, 14 (01) : 173A - 173A
  • [22] The relationship between BCL-2 and BCL-6 protein expression in diffuse large B-cell lymphoma (DLCL).
    Skinnider, BF
    DUpuis, B
    Gascoyne, RD
    MODERN PATHOLOGY, 1998, 11 (01) : 140A - 140A
  • [23] Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2091 - 2092
  • [24] Dual Expression of c-MYC and BCL2 Proteins Predicts Worse Outcomes in Diffuse Large B-Cell Lymphoma
    Schneider, Kelli
    Banks, Peter
    Collie, Angela
    Lanigan, Christopher
    Durkin, Lisa
    Hill, Brian
    Hsi, Eric
    LABORATORY INVESTIGATION, 2015, 95 : 376A - 376A
  • [25] Dual Expression of c-MYC and BCL2 Proteins Predicts Worse Outcomes in Diffuse Large B-Cell Lymphoma
    Schneiden, Kelli
    Banks, Peter
    Collie, Angela
    Lanigan, Christopher
    Durkin, Lisa
    Hill, Brian
    Hsi, Eric
    MODERN PATHOLOGY, 2015, 28 : 376A - 376A
  • [26] Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene
    Lima, Francisco Pignataro
    Bousquet, Marina
    Gomez-Brouchet, Anne
    de Paiva, Geisilene Russano
    Amstalden, Eliane Maria Ingrid
    Soares, Fernando Augusto
    Dastugue, Nicole
    Vassallo, Jose
    Brousset, Pierre
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) : 723 - 726
  • [27] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
    Scott, David W.
    King, Rebecca L.
    Staiger, Annette M.
    Ben-Neriah, Susana
    Jiang, Aixiang
    Horn, Heike
    Mottok, Anja
    Farinha, Pedro
    Slack, Graham W.
    Ennishi, Daisuke
    Schmitz, Norbert
    Pfreundschuh, Michael
    Nowakowski, Grzegorz S.
    Kahl, Brad S.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Ott, German
    Macon, William R.
    Rosenwald, Andreas
    BLOOD, 2018, 131 (18) : 2060 - 2064
  • [28] Expression. of p53, c-myc, or bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals
    Chang, CC
    Kampalath, B
    Schultz, C
    Bunyi-Teopengco, E
    Logan, B
    Eshoa, C
    Dincer, AP
    Perkins, SL
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (02) : 208 - 212
  • [29] BCL-6 AND THE MOLECULAR PATHOGENESIS OF B-CELL LYMPHOMA
    DALLAFAVERA, R
    YE, BH
    LOCOCO, F
    CHANG, CC
    CECHOVA, K
    ZHANG, J
    MIGLIAZZA, A
    MELLADO, W
    NIU, H
    CHAGANTI, S
    CHEN, W
    RAO, PH
    PARSA, NZ
    LOUIE, DC
    OFFIT, K
    CHAGANTI, RSK
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 117 - 123
  • [30] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162